Riskpilot← Back to searchSign inGet full accessGRESSVIK LEGER AS
ASActiveOrg 924576766Kapperstien 24, 1621 GressvikGeneral medical practice activities · NACE 8621Est. 20203 employees
Revenue 2024
NOK 2,5M
+30% vs 2023
EBITDA margin
3.9%
-14% vs 2023
Equity ratio
18.8%
Financial strength
Net profit 2024
NOK 29K
-66% vs 2023
| Revenue | NOK 2,5M | +30% |
| EBITDA | NOK 98K | -14% |
| Net profit | NOK 29K | -66% |
| Total assets | NOK 355K | +14% |
| Equity | NOK 67K | +78% |
| Employees | 3 | — |
Legal name
GRESSVIK LEGER AS
Org number
924576766
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
10. februar 2020
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Legevirksomhet og alt som naturlig faller inn under dette.
Address
Kapperstien 24, 1621 Gressvik
Phone
+4769361800
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 010 | 1 445 | 1 701 | 1 931 | 2 519 |
| Staff expenses | −414 | −735 | −761 | −868 | −1 122 |
| EBITDA | 7 | −105 | 43 | 113 | 98 |
| Depreciation & amort. | −0 | −3 | −10 | −24 | −60 |
| EBIT | 7 | −108 | 33 | 90 | 38 |
| Net financials | 0 | 0 | −0 | 0 | −0 |
| Profit before tax | 7 | −108 | 33 | 90 | 38 |
| Tax | −0 | −0 | −0 | 3 | 8 |
| Net profit | 7 | −108 | 33 | 87 | 29 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 178 | 96 | 168 | 310 | 355 |
| Equity | 26 | −82 | −49 | 38 | 67 |
| Long-term debt | 0 | 0 | 0 | 2 | 8 |
| Short-term debt | 153 | 179 | 217 | 271 | 280 |
| Total debt | 153 | 179 | 217 | 273 | 288 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20202024
Equity ratio
18.8%
This company
38.2%
Market median
-51% vs market
20202024
Return on equity
43.8%
This company
18.4%
Market median
+138% vs market
20202024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20202024
Asset turnover
7.10×
This company
1.12×
Market median
+534% vs market
20202024
Debt / equity
4.31×
This company
0.62×
Market median
-595% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20.0% | 20.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GRESSVIK LEGER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mufid Baker | Chief Executive Officer | 0 companies |
| Patrick Normann | Board of Directors | 0 companies |
| Patrick Normann Kristiansen | Board of Directors | 0 companies |
| Maren Næss Hopstad | Board of Directors | 0 companies |